- 全部删除
- 您的购物车当前为空
TrxR-IN-8 (Compound 6f) 是一种选择性TrxR抑制剂,IC50为10.2 μM。它通过刺激活性氧产生,减少细胞内硫醇,降低谷胱甘肽/谷胱甘肽比率,引发氧化应激,从而导致细胞凋亡 (apoptosis)。TrxR-IN-8 对非小细胞肺癌 (NSCLC) 细胞显示出显著的细胞毒性。
TrxR-IN-8 (Compound 6f) 是一种选择性TrxR抑制剂,IC50为10.2 μM。它通过刺激活性氧产生,减少细胞内硫醇,降低谷胱甘肽/谷胱甘肽比率,引发氧化应激,从而导致细胞凋亡 (apoptosis)。TrxR-IN-8 对非小细胞肺癌 (NSCLC) 细胞显示出显著的细胞毒性。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 待询 | 10-14周 | |
50 mg | 待询 | 10-14周 |
TrxR-IN-8 相关产品
产品描述 | TrxR-IN-8 (Compound 6f) is a selective inhibitor of TrxR with an IC50 of 10.2 μM. It induces apoptosis through oxidative stress by stimulating the production of reactive oxygen species, reducing intracellular thiols, and lowering the glutathione/glutathione disulfide ratio. TrxR-IN-8 exhibits significant cytotoxicity against non-small cell lung cancer (NSCLC) cells. |
分子量 | 381.21 |
分子式 | C16H16INO2 |
CAS No. | 2857180-28-8 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容